Kévin Vanvarenberg
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 4
- Pharmaceutical Science top 5%
- Genetics top 5%
- Glioma Diagnosis and Treatment 3
- Molecular Medicine top 10%
-
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 5
- Immune Cell Function and Interaction 3
-
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 4
-
- Nanoplatforms for cancer theranostics 5
- Co-authors
- Véronique PréatBernard UčakarFabienne DanhierGaëlle VandermeulenChiara BastiancichGuillaume BastiatFrédéric LagarceHéloïse Ragelle
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Kévin Vanvarenberg
35 papers receiving 960 citations
Peers
Comparison fields: 5 of 89
- Biomaterials 351
- Pharmaceutical Science 115
- Genetics 163
- Molecular Medicine 65
- Immunology 200
Countries citing papers authored by Kévin Vanvarenberg
This map shows the geographic impact of Kévin Vanvarenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kévin Vanvarenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kévin Vanvarenberg more than expected).
Fields of papers citing papers by Kévin Vanvarenberg
This network shows the impact of papers produced by Kévin Vanvarenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kévin Vanvarenberg. The network helps show where Kévin Vanvarenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kévin Vanvarenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 45 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 27 | |
| 12 | 2020 | 17 | |
| 13 | 2019 | 23 | |
| 14 | 2018 | 25 | |
| 15 | 2016 | 19 | |
| 16 | 2015 | 70 | |
| 17 | 2015 | 18 | |
| 18 | 2015 | 23 | |
| 19 | 2015 | 47 | |
| 20 | 2015 | 101 |
About Kévin Vanvarenberg
Kévin Vanvarenberg is a scholar working on Immunology, Pharmaceutical Science and Developmental Neuroscience, having authored 36 papers that have together received 963 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), RNA Interference and Gene Delivery (10 papers), Immune cells in cancer (5 papers), Nanoplatforms for cancer theranostics (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Glioma Diagnosis and Treatment (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Biomaterials (351 citations), Pharmaceutical Science (115 citations) and Genetics (163 citations). Kévin Vanvarenberg has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Véronique Préat, Bernard Učakar, Fabienne Danhier, Gaëlle Vandermeulen, Chiara Bastiancich, Guillaume Bastiat, Frédéric Lagarce, Héloïse Ragelle, Alessandra Lopes and Anne des Rieux.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.